Femasys closes ~$30M private placement of stock, pre-funded and milestone warrants

FEMASYS INC

Private placement: 5,013,559 shares, 4,361,440 pre-funded warrants, and 18,749,998 warrants at $3.20/share; ~$30M gross proceeds.
Common warrants exercisable at $2.95; pre-funded at $0.0001; milestone warrants require $1.5M quarterly revenue and 130% price trigger.
Insiders (CEO, CFO, COO, CTO, Chief Medical Officer) purchased ~$134k of securities on same terms as other investors.
Nantahala Capital (lead investor) gets board designee rights (up to 2) subject to ownership thresholds; prior board nomination rights from Pointillist convertible note terminated.
Registration rights agreement: file resale registration statement within 30 days of closing (August 10, 2026).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.